201 related articles for article (PubMed ID: 22610850)
1. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
Wala EP; Crooks PA; McIntosh JM; Holtman JR
Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
[TBL] [Abstract][Full Text] [Related]
2. The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.
Holtman JR; Dwoskin LP; Dowell C; Wala EP; Zhang Z; Crooks PA; McIntosh JM
Eur J Pharmacol; 2011 Nov; 670(2-3):500-8. PubMed ID: 21944926
[TBL] [Abstract][Full Text] [Related]
3. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
[TBL] [Abstract][Full Text] [Related]
4. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
[TBL] [Abstract][Full Text] [Related]
5. Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
Zheng G; Zhang Z; Dowell C; Wala E; Dwoskin LP; Holtman JR; McIntosh JM; Crooks PA
Bioorg Med Chem Lett; 2011 Apr; 21(8):2476-9. PubMed ID: 21397497
[TBL] [Abstract][Full Text] [Related]
6. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
9. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].
Li Z; Han X; Hong X; Li X; Gao J; Zhang H; Zheng A
Mar Drugs; 2021 Feb; 19(3):. PubMed ID: 33668830
[TBL] [Abstract][Full Text] [Related]
10. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.
Xiao W; Boroujerdi A; Bennett GJ; Luo ZD
Neuroscience; 2007 Jan; 144(2):714-20. PubMed ID: 17084535
[TBL] [Abstract][Full Text] [Related]
12. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats.
Huynh PN; Giuvelis D; Christensen S; Tucker KL; McIntosh JM
Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877728
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine.
Thibault K; Elisabeth B; Sophie D; Claude FZ; Bernard R; Bernard C
Eur J Pharmacol; 2008 Dec; 600(1-3):71-7. PubMed ID: 18938155
[TBL] [Abstract][Full Text] [Related]
14. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam.
Di Cesare Mannelli L; Maresca M; Farina C; Scherz MW; Ghelardini C
Neurotoxicology; 2015 Sep; 50():101-7. PubMed ID: 26254739
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
16. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
17. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
19. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
[TBL] [Abstract][Full Text] [Related]
20. Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.
Vincler M; McIntosh JM
Expert Opin Ther Targets; 2007 Jul; 11(7):891-7. PubMed ID: 17614758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
